October 4, 2015

In Vivo

Gilead Plays Hardball With Hep C Patient Assistance

By In Vivo Team

Gilead Sciences recently began limiting enrollment in its Sovaldi and Harvoni patient assistance program in an attempt to pressure payors to expand their coverage criteria. The big question is how payors are likely to react.

read full article >